Zomig - Treatment of Acute Migraine Headache in Adolescents

Completed · Phase 4 · Has a placebo group

Conditions studied: Migraine Headache

In brief

The purpose of this study is to investigate if Zomig® Nasal Spray will help children (age 12-17 years) with migraine headaches feel better. This will be done by comparing 3 different doses of Zomig Nasal Spray with placebo nasal spray (inactive treatment).

Key facts

Study ID
NCT01211145
Run by
AstraZeneca
People needed
1653
Starts
2010-09-01
Expected to finish
2013-10-01
Last updated by the study team
2016-05-18

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.